PMID- 26391515 OWN - NLM STAT- MEDLINE DCOM- 20160819 LR - 20181113 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 5 DP - 2015 Sep 22 TI - T cell immunity to glatiramer acetate ameliorates cognitive deficits induced by chronic cerebral hypoperfusion by modulating the microenvironment. PG - 14308 LID - 10.1038/srep14308 [doi] LID - 14308 AB - Vascular dementia (VaD) is a progressive and highly prevalent disorder. However, in a very large majority of cases, a milieu of cellular and molecular events common for multiple neurodegenerative diseases is involved. Our work focused on whether the immunomodulating effect of glatiramer acetate (GA) could restore normalcy to the microenvironment and ameliorate cognitive decline induced by chronic cerebral hypoperfusion. We assessed cognitive function by rats' performance in a Morris water maze (MWM), electrophysiological recordings and by pathologic changes. The results suggest that GA reduced cognitive deficits by reestablishing an optimal microenvironment such as increasing expression of the brain-derived neurotrophic factor (BDNF) and modulating the Th1/Th2 cytokine balance in the hippocampus. When microenvironmental homeostasis is restored, cholinergic activity becomes involved in ameliorating cellular damage. Since vaccination with GA can boost "protective autoimmunity" in this way, a similar strategy may have therapeutic potential for alleviating VaD disease. FAU - Chen, Li AU - Chen L AD - Department of Neurology and Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Yao, Yang AU - Yao Y AD - Department of Neurology and Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Wei, Changjuan AU - Wei C AD - Department of Neurology and Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Sun, Yanan AU - Sun Y AD - Department of Neurology and Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Ma, Xiaofeng AU - Ma X AD - Department of Neurology and Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. FAU - Zhang, Rongxin AU - Zhang R AD - Center for Basic Medical Science Research, Tianjin Medical University, Tianjin 300070, China. FAU - Xu, Xiaolin AU - Xu X AD - Department of Neurology, Tianjin Huanhu Hospital, Tianjin 300060, China. FAU - Hao, Junwei AU - Hao J AD - Department of Neurology and Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150922 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Aif1 protein, rat) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Calcium-Binding Proteins) RN - 0 (Cytokines) RN - 0 (Glial Fibrillary Acidic Protein) RN - 0 (Microfilament Proteins) RN - 5M691HL4BO (Glatiramer Acetate) SB - IM MH - Animals MH - Behavior, Animal/drug effects MH - Brain Ischemia/*complications/*immunology/metabolism/pathology MH - Brain-Derived Neurotrophic Factor/metabolism MH - Calcium-Binding Proteins/genetics/metabolism MH - Cognition Disorders/*etiology/metabolism MH - Cytokines/metabolism MH - Dementia, Vascular/etiology MH - Disease Models, Animal MH - Glatiramer Acetate/*immunology/pharmacology MH - Glial Fibrillary Acidic Protein/genetics/metabolism MH - Hippocampus/metabolism MH - Long-Term Potentiation/drug effects MH - Male MH - Maze Learning/drug effects MH - Microfilament Proteins/genetics/metabolism MH - Rats MH - T-Lymphocytes/*immunology/metabolism PMC - PMC4585746 EDAT- 2015/09/24 06:00 MHDA- 2016/08/20 06:00 PMCR- 2015/09/22 CRDT- 2015/09/23 06:00 PHST- 2015/03/20 00:00 [received] PHST- 2015/08/24 00:00 [accepted] PHST- 2015/09/23 06:00 [entrez] PHST- 2015/09/24 06:00 [pubmed] PHST- 2016/08/20 06:00 [medline] PHST- 2015/09/22 00:00 [pmc-release] AID - srep14308 [pii] AID - 10.1038/srep14308 [doi] PST - epublish SO - Sci Rep. 2015 Sep 22;5:14308. doi: 10.1038/srep14308.